Insufficient scRNA-seq data for expression of CDK15 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 96% | 322.76 | 1735 / 1809 | 34% | 1.45 | 160 / 472 |
breast | 96% | 165.10 | 439 / 459 | 26% | 0.45 | 287 / 1118 |
ovary | 100% | 878.19 | 180 / 180 | 9% | 0.18 | 37 / 430 |
uterus | 96% | 96.43 | 164 / 170 | 6% | 0.14 | 29 / 459 |
bladder | 100% | 168.62 | 21 / 21 | 2% | 0.03 | 11 / 504 |
stomach | 95% | 101.52 | 342 / 359 | 3% | 0.09 | 9 / 286 |
lung | 92% | 129.43 | 531 / 578 | 6% | 0.09 | 72 / 1155 |
adipose | 96% | 144.50 | 1158 / 1204 | 0% | 0 | 0 / 0 |
prostate | 92% | 142.71 | 225 / 245 | 1% | 0.02 | 6 / 502 |
blood vessel | 92% | 166.99 | 1226 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 88% | 113.10 | 1265 / 1445 | 3% | 0.05 | 5 / 183 |
intestine | 85% | 91.01 | 824 / 966 | 2% | 0.03 | 8 / 527 |
adrenal gland | 43% | 21.39 | 111 / 258 | 17% | 0.79 | 39 / 230 |
muscle | 52% | 41.44 | 421 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 44% | 2.24 | 35 / 80 |
kidney | 34% | 28.26 | 30 / 89 | 4% | 0.09 | 32 / 901 |
thymus | 37% | 21.08 | 240 / 653 | 0% | 0.00 | 2 / 605 |
heart | 32% | 15.72 | 279 / 861 | 0% | 0 | 0 / 0 |
pancreas | 14% | 5.58 | 46 / 328 | 14% | 0.18 | 25 / 178 |
brain | 14% | 6.53 | 377 / 2642 | 7% | 0.14 | 48 / 705 |
spleen | 5% | 1.95 | 12 / 241 | 0% | 0 | 0 / 0 |
liver | 2% | 0.62 | 4 / 226 | 1% | 0.02 | 3 / 406 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
peripheral blood | 0% | 0.22 | 4 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006468 | Biological process | protein phosphorylation |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0030332 | Molecular function | cyclin binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004693 | Molecular function | cyclin-dependent protein serine/threonine kinase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
Gene name | CDK15 |
Protein name | Cyclin-dependent kinase 15 (EC 2.7.11.22) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 7 protein) (Cell division protein kinase 15) (Serine/threonine-protein kinase ALS2CR7) (Serine/threonine-protein kinase PFTAIRE-2) Cyclin dependent kinase 15 |
Synonyms | PFTK2 ALS2CR7 |
Description | FUNCTION: Serine/threonine-protein kinase that acts like an antiapoptotic protein that counters TRAIL/TNFSF10-induced apoptosis by inducing phosphorylation of BIRC5 at 'Thr-34'. . |
Accessions | ENST00000434439.1 [Q96Q40-3] F8WDP7 ENST00000260967.6 [Q96Q40-4] Q96Q40 ENST00000652192.3 [Q96Q40-1] ENST00000451080.5 ENST00000450471.6 [Q96Q40-5] ENST00000410091.7 [Q96Q40-4] |